Lab21 | GenomeWeb

Lab21

Novacyt announced a €3.1 million ($3.8 million) private equity placement to open new markets and develop infectious disease diagnostics.

NEW YORK (GenomeWeb) — Molecular testing methods such as nucleic acid sequence-based amplification (NASBA) and qPCR, administered either in combination or separately, are superior to routinely used ELISA-based assays for diagnosing invasive aspergillosis, according to a newly published retrospect

NEW YORK (GenomeWeb) – Liquid-based cytology diagnostics firm Novacyt today announced its intention to combine with Lab21 in a stock-for-stock transaction valued at approximately €40 million ($34.1 million).

NEW YORK (GenomeWeb News) – UK diagnostics firm Lab21 today announced an expansion of a distribution agreement with Quidel to include AnDiaTec's real-time PCR tests in the UK.

French molecular diagnostics and clinical genomics services firm IntegraGen said this week that it has obtained exclusive rights to a microRNA biomarker that can help predict therapeutic outcomes in non-KRAS mutated metastatic colorectal cancer patients being treated with epiderm

Irish clinical diagnostics company Trinity Biotech has acquired the blood bank screening and certain molecular assets of UK-based personalized medicine and clinical diagnostics firm Lab21, the companies said today.

UK-based clinical diagnostics developer Lab21 said last week that it has inked an agreement with IntegraGen to develop a microRNA assay for colorectal cancer designed to improve patient outcomes.

British diagnostics service firmLab21 said this week that it has signed a deal to collaborate with diagnostics developer IntegraGen to develop a microRNA-based assay for colorectal cancer.

NEW YORK (GenomeWeb News) – Lab21 today announced an agreement with IntegraGen to develop a microRNA-based assay to identify colorectal cancer patients who may best respond to EGFR-inhibitor therapy.

Lumora has hired Hayden Jeffreys as its commercial director. Jeffreys previously was divisional director of diagnostic products at Lab21, and he has held posts at Gen-Probe, Molecular Light Technology, and Invitron.

Pages

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.